Beijing SL Pharmaceutical Co Ltd 002038.SZ

Last Updated: May 15, 12:00 AM·SZSE

Beijing SL Pharmaceutical Co Ltd

Beijing SL Pharmaceutical Co Ltd. Stock Analysis 002038.SZ

China Health Care Small Cap
Beijing SL Pharmaceutical Co., Ltd. engages in the research, development, production and operation of genetic engineering and biochemical drugs. The company is headquartered in Beijing, Beijing and currently employs 901 full-time employees. The company went IPO on 2004-09-09. The firm's main products include complex coenzyme, arsenic trioxide, recombinant human granulocyte stimulating factor, recombinant human interleukin-2, recombinant human basic fibroblast growth factor, thymopentin, enoxaparin and Xingling dropping pills. The firm's drugs can be used to treat tumors, cardiovascular and cerebrovascular diseases, anti-infection immunity, metabolic diseases, wound repair, liver diseases, kidney diseases and rare diseases. The firm mainly operates its businesses in the domestic and overseas markets.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.